In xenograft models, the treatment of rapamycin enriched the population of CD133+ cells and promoted tumorigenesis of HCC cells.142 Altogether, the data from several groups suggested the dual role of mTOR signaling in cancer stem cells in human malignancies. The gene discussed is MTOR; the disease is cancer.